TickerFactsScreenerDevelopers

Tempest Therapeutics, Inc. (TPST) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2012: $849.0K2013: $719.0K2014: $2.80M2015: $5.23M2016: $2.59M2017: $4.0K2018: $36.0K2019: $397.0K2020: $50.0K2021: $135.0K2022: $562.0K2023: $170.0K2024: $435.0K2025: $0$0
2012Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$435.0K+155.9%
2023$170.0K-69.8%
2022$562.0K+316.3%
2021$135.0K+170.0%
2020$50.0K-87.4%
2019$397.0K+1002.8%
2018$36.0K+800.0%
2017$4.0K-99.8%
2016$2.59M-50.5%
2015$5.23M+86.5%
2014$2.80M+290.0%
2013$719.0K-15.3%
2012$849.0K—